The session will cover the most up-to-date information on the therapeutic potential of psychedelic substances and the latest findings on their effects on mental health and well-being.
This presentation will discuss the construct of ‘connectedness to self, others and world’, why it is so crucial at this time, and consider how psychedelic therapy can boost it. However, in order for a sense of connectedness to last, we need to nurture the social and environmental container that participants come from and return to after a session. It is not enough to hope that psychedelic medicines will transform our toxic culture, because if we don’t start to build a more compassionate infrastructure, psychedelics could just amplify rather than heal the problems at our collective roots. Psychedelic therapists can play a role in supporting the development of community connectedness: not only is this important for optimizing and safeguarding psychedelic therapy, it will also make it cheaper, and more scalable, sustainable, and regenerative.
As clinicians, we all want to better serve our patients but sadly, mental health outcomes are lackluster at best. As the story of psychedelic-assisted therapy began to circulate, we were excited about the possibilities. Even though the field is rapidly developing, opinions about psychedelic-assisted psychotherapy vary as do outcomes. Additionally, there is a lack of standardized protocols and training. This session will explore the world of psychedelic-assisted psychotherapy, the practice of combining psychedelics with therapeutic techniques for healing. We will delve into the history of psychedelic-assisted therapy, its practical applications, and some promising results in using this approach in treating mental health conditions. Ethical considerations and future directions will also be discussed.
In this session, Chantelle Thomas will review ways in which Ketamine and Esketamine are being used to better the outcomes of patients with some of the most devastating mental health conditions, such as addiction, PTSD, and treatment resistant depression. Providing practical tips for the use of Ketamine and Esketamine in clinical practice, including dosing, administration, monitoring, and patient selection. She will teach you how you can help your patients safely and legally access ketamine treatment, as well as prepare for and integrate those treatments into practice by using a psychedelic-assisted therapy framework.
Dan Rome will cover the important issue of how to make psychedelic medicine readily accessible and affordable to all who can benefit from it.
A theoretical seminar that will discuss the burgeoning field of psychedelic-assisted therapy. Including a somatic focus in this work-as well as recognizing the importance of therapists, guides, and sitters being prepared for the possible emergence of trauma-will be discussed. The presenters will report some of their own observations, including reflections on their work supporting the integration of psychedelic experiences with their clients. They will detail how to ground expanded states of consciousness in the body and support access to the here-and-now through the felt sense. Experiential exercises useful for the preparation and integration phases of this work will be introduced for attendees.
This presentation will discuss the updates and uses of various psychedelics for addiction treatment and examine how and why they show promise in this field. It will also highlight the objectives, methodologies, and preliminary findings of various research studies on the use of psychedelics in addiction treatment.